Web Desc
Asthma: From Pathway Biology to Precision Therapeutics
Organizer(s): Clare M. Lloyd, John V. Fahy and Sally Wenzel-Morganroth
Date: February 12 - 16, 2017
Location: Keystone Resort, Keystone, CO, USA
Supported by AstraZeneca and Theravance Biopharma
Summary of Meeting:
Asthma affects people from childhood to old age and causes significant public health problems with great economic consequences. The type 2 inflammation pathway is considered the dominant mechanism of asthma, but clinical trials of recently developed treatments targeting this pathway indicate that large numbers of asthmatics do not benefit from this therapeutic approach. This limited effect of type 2 inhibitors, coupled with recent advances in our understanding of the clinical diversity of asthma, underscores the heterogeneous nature of the underlying disease mechanisms. The aims of this meeting are to focus on the heterogeneous disease biology of asthma and to explore how treatments can advance from a one-size-fits-all paradigm to one in which asthmatics receive personalized treatments based on biomarkers that classify their specific disease mechanism. The meeting program will combine cutting-edge presentations on the molecular mechanisms of inflammation and remodeling in asthma with others that address the complexity of clinical phenotypes of asthma, and will include updates on the application of new technologies to develop biomarkers to guide personalized treatment. Anticipated outcomes include greater understanding of mechanisms of disease other than type 2 inflammation and appreciation of the need to forge stronger collaborations between clinical and basic scientists to advance the goal of personalized asthma treatment. The overarching goal of the meeting is to bring together world-class researchers with expertise in immunology, cell biology and asthma disease biology to permit exchange of ideas and facilitate development of new scientific directions and therapeutic approaches for asthma.
Scholarship Deadline: October 13 2016
Discounted Abstract Deadline: October 13 2016
Abstract Deadline: November 16 2016
Discounted Registration Deadline: December 14 2016
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
AstraZenecaTheravance Biopharma
We gratefully acknowledge additional support for this conference from:
SCIREQ Scientific Respiratory Equipment Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Genentech, Inc.

MedImmune

Regeneron Pharmaceuticals, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL135875-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, February 12 | 4:00PM - 8:00PM
Arrival and Registration
Room: Keystone Lodge Lobby


Sunday, February 12 | 6:00PM - 8:00PM
Welcome Mixer
Room: Keystone Lodge-Bighorn Bar
No registration fees are used to fund alcohol served at this function.

Monday, February 13 | 7:00AM - 8:00AM
Breakfast
Room: Divide & Ten Mile


Monday, February 13 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Arapahoe

Speaker 1 of 2
* Clare M. Lloyd, Imperial College London, UK

Monday, February 13 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Arapahoe

Speaker 2 of 2
Avrum Spira, Boston University, USA
The Airway Transcriptome for Precision Lung Cancer Detection

Monday, February 13 | 9:00AM - 11:30AM
Asthma: Progress, Pathogenesis and Phenotypes
Room: Arapahoe

Speaker 1 of 7
* Joseph R. Arron, Genentech, Inc., USA

Monday, February 13 | 9:00AM - 11:30AM
Asthma: Progress, Pathogenesis and Phenotypes
Room: Arapahoe

Speaker 2 of 7
Wendy C. Moore, Wake Forest School of Medicine, USA
Cluster Phenotypes and Personalized Medicine in the Clinic

Monday, February 13 | 9:00AM - 11:30AM
Asthma: Progress, Pathogenesis and Phenotypes
Room: Arapahoe


Coffee Break

Monday, February 13 | 9:00AM - 11:30AM
Asthma: Progress, Pathogenesis and Phenotypes
Room: Arapahoe

Speaker 4 of 7
John V. Fahy, University of California, San Francisco, USA
Role of IL-6 and Systemic Inflammation in Asthma Pathogenesis

Monday, February 13 | 9:00AM - 11:30AM
Asthma: Progress, Pathogenesis and Phenotypes
Room: Arapahoe

Speaker 5 of 7
Fernando D. Martinez, University of Arizona, USA
Early Origins of Asthma

Monday, February 13 | 9:00AM - 11:30AM
Asthma: Progress, Pathogenesis and Phenotypes
Room: Arapahoe

Speaker 6 of 7
Kedir N. Turi, Vanderbilt University, USA
Short Talk: Identification of Infant Acute Respiratory Illness Cytokine-Response Subgroups Associated with Recurrent Wheezing Phenotype

Monday, February 13 | 9:00AM - 11:30AM
Asthma: Progress, Pathogenesis and Phenotypes
Room: Arapahoe

Speaker 7 of 7
Zala Rojnik, AstraZeneca, Sweden
Short Talk: IL-6 Trans-Signaling Gene Signature Reveals an Asthma Subtype with Increased Mucosal Infiltration of Immune Cells

Monday, February 13 | 11:30AM - 2:30PM
On Own for Lunch


Monday, February 13 | 11:30AM - 1:00PM
Poster Setup
Room: Divide & Ten Mile


Monday, February 13 | 1:00PM - 10:00PM
Poster Viewing
Room: Divide & Ten Mile


Monday, February 13 | 2:30PM - 4:30PM
Workshop 1: Phenotyping Methods/Cluster Analysis
Room: Arapahoe

Speaker 1 of 8
* Lauren E. Cohn, Yale University, USA

Monday, February 13 | 2:30PM - 4:30PM
Workshop 1: Phenotyping Methods/Cluster Analysis
Room: Arapahoe

Speaker 2 of 8
Anthony Bosco, Telethon Kids Institute, Australia
Persistent Activation of Interlinked Th2-Airway Epithelial Gene Networks in Sputum-Derived Cells from Aeroallergen-Sensitized Symptomatic Atopic Asthmatics

Monday, February 13 | 2:30PM - 4:30PM
Workshop 1: Phenotyping Methods/Cluster Analysis
Room: Arapahoe

Speaker 3 of 8
Peter McErlean, Kings College London, UK
Epigenetic Landscape of the Asthmatic Airways

Monday, February 13 | 2:30PM - 4:30PM
Workshop 1: Phenotyping Methods/Cluster Analysis
Room: Arapahoe

Speaker 4 of 8
Johan Kolmert, Karolinska Institutet, Sweden
Urinary Eicosanoid-Based Sub-Phenotyping in the U-BIOPRED Severe Asthma Cohort Demonstrates Phenotype Stability between Baseline and Longitudinal Sampling

Monday, February 13 | 2:30PM - 4:30PM
Workshop 1: Phenotyping Methods/Cluster Analysis
Room: Arapahoe

Speaker 5 of 8
Michael Peters, University of California, San Francisco, USA
Sputum RNA-Seq Analysis Reveals Novel Asthma Endotypes Characterized by Cell-Type Specific Signatures

Monday, February 13 | 2:30PM - 4:30PM
Workshop 1: Phenotyping Methods/Cluster Analysis
Room: Arapahoe

Speaker 6 of 8
Marc Massanari, Circassia, USA
Impact of FeNO on Treatment Decisions: Results from the ASTH2MA (ASsessment of TH2 inflamMAtion) Survey

Monday, February 13 | 2:30PM - 4:30PM
Workshop 1: Phenotyping Methods/Cluster Analysis
Room: Arapahoe

Speaker 7 of 8
Xiting Yan, Yale University School of Medicine, USA
Longitudinal RNA Sequencing Data of Induced Sputum in Asthma Patients Reveals Stable Transcriptional Endotypes of Asthma Associated with Asthma Severity

Monday, February 13 | 2:30PM - 4:30PM
Workshop 1: Phenotyping Methods/Cluster Analysis
Room: Arapahoe

Speaker 8 of 8
Samir Kelada, University of North Carolina at Chapel Hill, USA
Meta- and Sub-type Analysis of Airway Epithelia Gene Expression in Asthma

Monday, February 13 | 4:30PM - 5:00PM
Coffee Available
Room: Gallery


Monday, February 13 | 5:00PM - 7:00PM
Complex Phenotypes and How to Approach Them
Room: Arapahoe

Speaker 1 of 5
* Sally Wenzel-Morganroth, University of Pittsburgh, USA

Monday, February 13 | 5:00PM - 7:00PM
Complex Phenotypes and How to Approach Them
Room: Arapahoe

Speaker 2 of 5
Eric P. Xing, Carnegie Mellon University, USA
Toward Personalized Pan-Omic Association Analysis under Complex Structures

Monday, February 13 | 5:00PM - 7:00PM
Complex Phenotypes and How to Approach Them
Room: Arapahoe

Speaker 3 of 5
Anne Dixon, University of Vermont College of Medicine, USA
Obesity and Asthma

Monday, February 13 | 5:00PM - 7:00PM
Complex Phenotypes and How to Approach Them
Room: Arapahoe

Speaker 4 of 5
Sejal Saglani, Imperial College London, UK
Severe Therapy Resistant Asthma in Children: Translational Approaches to Uncover Sub-phenotypes

Monday, February 13 | 5:00PM - 7:00PM
Complex Phenotypes and How to Approach Them
Room: Arapahoe

Speaker 5 of 5
Kapil Gadkar, Genentech, Inc., USA
Short Talk: A Mechanistic Systems Pharmacology Model for Evaluating Potential Drugs for Treatment of Asthma

Monday, February 13 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Divide & Ten Mile
No registration fees are used to fund alcohol served at this function.

Monday, February 13 | 7:30PM - 10:00PM
Poster Session 1
Room: Divide & Ten Mile


Tuesday, February 14 | 7:00AM - 8:00AM
Breakfast
Room: Divide & Ten Mile


Tuesday, February 14 | 8:00AM - 11:15AM
Regulation and Treatment of Type 2 Inflammation in the Airwa
y

Room: Arapahoe

Speaker 1 of 8
* John V. Fahy, University of California, San Francisco, USA

Tuesday, February 14 | 8:00AM - 11:15AM
Regulation and Treatment of Type 2 Inflammation in the Airwa
y

Room: Arapahoe

Speaker 2 of 8
Andrew D. Luster, Massachusetts General Hospital, USA
Regulatory T Cell Subsets in Type 2 Airway Inflammation

Tuesday, February 14 | 8:00AM - 11:15AM
Regulation and Treatment of Type 2 Inflammation in the Airwa
y

Room: Arapahoe

Speaker 3 of 8
Clare M. Lloyd, Imperial College London, UK
Epithelial Cells as Master Regulators of Pulmonary Inflammation

Tuesday, February 14 | 8:00AM - 11:15AM
Regulation and Treatment of Type 2 Inflammation in the Airwa
y

Room: Arapahoe


Coffee Break

Tuesday, February 14 | 8:00AM - 11:15AM
Regulation and Treatment of Type 2 Inflammation in the Airwa
y

Room: Arapahoe

Speaker 5 of 8
Anne I. Sperling, University of Chicago, USA
Differences in Asthma and Atopy Risk are Associated with Altered Immune Phenotypes: Studies in Amish and Hutterite Farm Children

Tuesday, February 14 | 8:00AM - 11:15AM
Regulation and Treatment of Type 2 Inflammation in the Airwa
y

Room: Arapahoe

Speaker 6 of 8
Carla V. Rothlin, Yale University, USA
Negative Regulation of Type 2 Immunity

Tuesday, February 14 | 8:00AM - 11:15AM
Regulation and Treatment of Type 2 Inflammation in the Airwa
y

Room: Arapahoe

Speaker 7 of 8
Irma Tindemans, Erasmus MC, Netherlands
Short Talk: Notch Signaling in T Cells is Essential for Allergic Airway Inflammation, but Expression of the Notch Ligand Jagged on Dendritic Cells and Lymph Node Stromal Cells is Dispensable

Tuesday, February 14 | 8:00AM - 11:15AM
Regulation and Treatment of Type 2 Inflammation in the Airwa
y

Room: Arapahoe

Speaker 8 of 8
Rafael de Queiroz Prado, NIAID, National Institutes of Health, USA
Short Talk: IL-4R-Alpha Signaling in Myeloid Cells Regulates Neutrophil-Induced Inflammation in Asthma

Tuesday, February 14 | 11:15AM - 5:00PM
On Own for Lunch


Tuesday, February 14 | 11:15AM - 1:00PM
Poster Setup
Room: Divide & Ten Mile


Tuesday, February 14 | 1:00PM - 10:00PM
Poster Viewing
Room: Divide & Ten Mile


Tuesday, February 14 | 4:30PM - 5:00PM
Coffee Available
Room: Gallery


Tuesday, February 14 | 5:00PM - 7:00PM
Novel Pathways Underlying Complex Phenotypes of Asthma
Room: Arapahoe

Speaker 1 of 5
* Anuradha Ray, University of Pittsburgh School of Medicine, USA

Tuesday, February 14 | 5:00PM - 7:00PM
Novel Pathways Underlying Complex Phenotypes of Asthma
Room: Arapahoe

Speaker 2 of 5
Bruce D. Levy, Brigham and Women's Hospital, USA
Regulation of Airway Innate Immunity by Specialized Pro-Resolving Mediators

Tuesday, February 14 | 5:00PM - 7:00PM
Novel Pathways Underlying Complex Phenotypes of Asthma
Room: Arapahoe

Speaker 3 of 5
Prescott G. Woodruff, University of California, San Francisco, USA
Non-type 2 Inflammatory Pathways in Asthma

Tuesday, February 14 | 5:00PM - 7:00PM
Novel Pathways Underlying Complex Phenotypes of Asthma
Room: Arapahoe

Speaker 4 of 5
Max A. Seibold, National Jewish Health, USA
Dual RNA-seq Reveals Respiratory Virus Infection in Asthmatic Children without Respiratory Illness is Associated with Changes in the Airway Transcriptome

Tuesday, February 14 | 5:00PM - 7:00PM
Novel Pathways Underlying Complex Phenotypes of Asthma
Room: Arapahoe

Speaker 5 of 5
Padraic Fallon, Trinity College Dublin, Ireland
Short Talk: A Mouse Model of Spontaneous IL-17 Dependent Asthma

Tuesday, February 14 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Divide & Ten Mile
No registration fees are used to fund alcohol served at this function.

Tuesday, February 14 | 7:30PM - 10:00PM
Poster Session 2
Room: Divide & Ten Mile


Wednesday, February 15 | 7:00AM - 8:00AM
Breakfast
Room: Divide & Ten Mile


Wednesday, February 15 | 8:00AM - 11:15AM
Influence of Pathogenic and Protective Microbes
Room: Arapahoe

Speaker 1 of 8
* Clare M. Lloyd, Imperial College London, UK

Wednesday, February 15 | 8:00AM - 11:15AM
Influence of Pathogenic and Protective Microbes
Room: Arapahoe

Speaker 2 of 8
Benjamin J. Marsland, Monash University, Australia
Influence of the Microbiome on the Development of Asthma

Wednesday, February 15 | 8:00AM - 11:15AM
Influence of Pathogenic and Protective Microbes
Room: Arapahoe

Speaker 3 of 8
Anuradha Ray, University of Pittsburgh School of Medicine, USA
Infections and Immune Responses Impacting Asthma Inception and Severity

Wednesday, February 15 | 8:00AM - 11:15AM
Influence of Pathogenic and Protective Microbes
Room: Arapahoe


Coffee Break

Wednesday, February 15 | 8:00AM - 11:15AM
Influence of Pathogenic and Protective Microbes
Room: Arapahoe

Speaker 5 of 8
Nathan W. Bartlett, University of Newcastle, Australia
Mechanisms of Virus Induced Exacerbations of Asthma

Wednesday, February 15 | 8:00AM - 11:15AM
Influence of Pathogenic and Protective Microbes
Room: Arapahoe

Speaker 6 of 8
Roland W. Kolbeck, MedImmune, LLC, USA
Targeted Treatment of Inflammatory Mediators of Asthma



Wednesday, February 15 | 8:00AM - 11:15AM
Influence of Pathogenic and Protective Microbes
Room: Arapahoe

Speaker 7 of 8
Henry J. McSorley, Queen's Medical Research Institute, UK
Short Talk: A Helminth-Derived Suppressor of the IL-33 Pathway

Wednesday, February 15 | 8:00AM - 11:15AM
Influence of Pathogenic and Protective Microbes
Room: Arapahoe

Speaker 8 of 8
Daniel J. Spakowicz, Yale University, USA
Short Talk: Using Microbial Composition within Sputum Transcriptome Data to Stratify Patients by Asthma Severity

Wednesday, February 15 | 11:15AM - 5:00PM
On Own for Lunch


Wednesday, February 15 | 11:15AM - 1:00PM
Poster Setup
Room: Divide & Ten Mile


Wednesday, February 15 | 1:00PM - 10:00PM
Poster Viewing
Room: Divide & Ten Mile


Wednesday, February 15 | 4:30PM - 5:00PM
Coffee Available
Room: Gallery


Wednesday, February 15 | 5:00PM - 7:00PM
How Does Tissue Remodeling Influence Disease Phenotype?
Room: Arapahoe

Speaker 1 of 5
* Steve Georas, University of Rochester Medical Center, USA

Wednesday, February 15 | 5:00PM - 7:00PM
How Does Tissue Remodeling Influence Disease Phenotype?
Room: Arapahoe

Speaker 2 of 5
James G. Martin, McGill University, Canada
Airway Smooth Muscle Hypercontractility in Asthma

Wednesday, February 15 | 5:00PM - 7:00PM
How Does Tissue Remodeling Influence Disease Phenotype?
Room: Arapahoe

Speaker 3 of 5
Jeffrey A. Whitsett, Cincinnati Children's Hospital Medical Center, USA
Transcriptional Networks Linking Goblet Cell Differentiation and Innate Immunity in the Pathogenesis of Asthma

Wednesday, February 15 | 5:00PM - 7:00PM
How Does Tissue Remodeling Influence Disease Phenotype?
Room: Arapahoe

Speaker 4 of 5
Philip Hansbro, University of Newcastle, Australia
Understanding Pathogenesis to Develop New Therapies for Severe Asthma

Wednesday, February 15 | 5:00PM - 7:00PM
How Does Tissue Remodeling Influence Disease Phenotype?
Room: Arapahoe

Speaker 5 of 5
Mikael Adner, Karolinska Institutet, Sweden
Short Talk: Interleukin-13 Induces Glucocorticoid-Insensitive Hyperreactivity of Human Small Airways

Wednesday, February 15 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Divide & Ten Mile
No registration fees are used to fund alcohol served at this function.

Wednesday, February 15 | 7:30PM - 10:00PM
Poster Session 3
Room: Divide & Ten Mile


Thursday, February 16 | 7:00AM - 8:00AM
Breakfast
Room: Divide & Ten Mile


Thursday, February 16 | 8:00AM - 11:15AM
Biomarkers for Personalized Treatment
Room: Arapahoe

Speaker 1 of 8
* Roland W. Kolbeck, MedImmune, LLC, USA

Thursday, February 16 | 8:00AM - 11:15AM
Biomarkers for Personalized Treatment
Room: Arapahoe

Speaker 2 of 8
Joseph R. Arron, Genentech, Inc., USA
The Virtuous Cycle: Biomarkers and Translational Research in Asthma Drug Development

Thursday, February 16 | 8:00AM - 11:15AM
Biomarkers for Personalized Treatment
Room: Arapahoe

Speaker 3 of 8
David Beebe, University of Wisconsin, USA
Potential of Microfluidic Technology to Identify Biomarkers of Specific Disease Phenotypes

Thursday, February 16 | 8:00AM - 11:15AM
Biomarkers for Personalized Treatment
Room: Arapahoe


Coffee Break

Thursday, February 16 | 8:00AM - 11:15AM
Biomarkers for Personalized Treatment
Room: Arapahoe

Speaker 5 of 8
Peter Ghazal, Cardiff University, UK
The Inflammatory Response in Early Life

Thursday, February 16 | 8:00AM - 11:15AM
Biomarkers for Personalized Treatment
Room: Arapahoe

Speaker 6 of 8
Erin Duncan Gordon, University of California, San Francisco, USA
Genetic Biomarkers to Guide Precision Medicine in Asthma: IL1RL1 Asthma Risk Variants

Thursday, February 16 | 8:00AM - 11:15AM
Biomarkers for Personalized Treatment
Room: Arapahoe

Speaker 7 of 8
Sudipto Saha, Bose Institute, India
Short Talk: Plasma Apolipoproteins - Potential Biomarkers in Atopic Asthma Based on LC-MS/MS Study  

Thursday, February 16 | 8:00AM - 11:15AM
Biomarkers for Personalized Treatment
Room: Arapahoe

Speaker 8 of 8
Anna J. James, Karolinska Institutet, Sweden
Short Talk: Local and Systemic Periostin Levels Both Reflect Processes of Relevance to Asthma

Thursday, February 16 | 11:15AM - 2:30PM
On Own for Lunch


Thursday, February 16 | 2:30PM - 4:30PM
Workshop 2: Modeling Complex Diseases in vivo and in vitro
Room: Arapahoe

Speaker 1 of 7
* Philip Hansbro, University of Newcastle, Australia

Thursday, February 16 | 2:30PM - 4:30PM
Workshop 2: Modeling Complex Diseases in vivo and in vitro
Room: Arapahoe

Speaker 2 of 7
Tibor Z. Veres, NIAID, National Institutes of Health, USA
Allergen-Induced CD4+ T-Cell Cytokine Production within Airway Mucosal DC-T-Cell Clusters Drives the Local Recruitment of Myeloid Effector Cells

Thursday, February 16 | 2:30PM - 4:30PM
Workshop 2: Modeling Complex Diseases in vivo and in vitro
Room: Arapahoe

Speaker 3 of 7
Daniel Camacho, University of Chicago, USA
IRF4(+) Dendritic Cells Promote Th2 Initiation in Response to Allergen

Thursday, February 16 | 2:30PM - 4:30PM
Workshop 2: Modeling Complex Diseases in vivo and in vitro
Room: Arapahoe

Speaker 4 of 7
Sangwoon Chung, Ohio State University, USA
FoxO1, A Potential Link Player Between Alternatively Activate Macrophages and Asthmatic Lung inflammation

Thursday, February 16 | 2:30PM - 4:30PM
Workshop 2: Modeling Complex Diseases in vivo and in vitro
Room: Arapahoe

Speaker 5 of 7
Stokes S. Peebles, Vanderbilt University Medical Center, USA
Glucagon Like Peptide-1 Receptor Signaling Inhibits Both Lung Innate and Adaptive Immunity Mediated Allergic Inflammation to Inhaled Aeroallergen

Thursday, February 16 | 2:30PM - 4:30PM
Workshop 2: Modeling Complex Diseases in vivo and in vitro
Room: Arapahoe

Speaker 6 of 7
Nora A. Barrett, Brigham and Women's Hospital, USA
LTE4/GPR99 Regulation of Respiratory Epithelial Cell Function  

Thursday, February 16 | 2:30PM - 4:30PM
Workshop 2: Modeling Complex Diseases in vivo and in vitro
Room: Arapahoe

Speaker 7 of 7
Heleen Vroman, Erasmus MC, Netherlands
TNFAIP3 Levels in Lung Dendritic Cells Instruct Th2 or Th17 Cell Differentiation in Eosinophilic or Neutrophilic Asthma

Thursday, February 16 | 4:30PM - 5:00PM
Coffee Available
Room: Gallery


Thursday, February 16 | 5:00PM - 6:45PM
Doing Better Going Forward
Room: Arapahoe

Speaker 1 of 5
* Clare M. Lloyd, Imperial College London, UK

Thursday, February 16 | 5:00PM - 6:45PM
Doing Better Going Forward
Room: Arapahoe

Speaker 2 of 5
* John V. Fahy, University of California, San Francisco, USA

Thursday, February 16 | 5:00PM - 6:45PM
Doing Better Going Forward
Room: Arapahoe

Speaker 3 of 5
Steven M. Rowe, University of Alabama at Birmingham, USA
Transformative Treatments - How the Cystic Fibrosis Community Did It

Thursday, February 16 | 5:00PM - 6:45PM
Doing Better Going Forward
Room: Arapahoe

Speaker 4 of 5
Jennifer Davidson Hamilton, Regeneron Pharmaceuticals, Inc., USA
Targeted Therapeutics: What Have They Taught Us About Pathomechanisms in Asthma?

Thursday, February 16 | 5:00PM - 6:45PM
Doing Better Going Forward
Room: Arapahoe

Speaker 5 of 5
Sally Wenzel-Morganroth, University of Pittsburgh, USA
Evolving Phenotypes to Endotypes: Is Precision Medicine Achievable in Asthma?

Thursday, February 16 | 6:45PM - 7:00PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Arapahoe


Thursday, February 16 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Divide & Ten Mile
No registration fees are used to fund alcohol served at this function.

Thursday, February 16 | 8:00PM - 11:00PM
Entertainment
Room: Divide & Ten Mile
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Thursday, February 16 | 8:00PM - 11:00PM
Cash Bar
Room: Divide & Ten Mile


Friday, February 17 | 10:25AM - 10:25AM
Departure


*Session Chair.